ABCA1活性遗传修饰因子与APOE亚型交互影响阿尔茨海默病风险
本研究利用ADSP、UK Biobank和ADES数据,分析ABCA1变异在APOE亚组中对AD风险的影响及与APOE ε2/ε4的交互作用。发现损伤性非同义ABCA1变异与APOE基因型存在交互效应,基于HDL相关变异构建的ABCA1活性预测与AD风险降低相关并与APOE ε4交互;ABCA1错义变异N1800H和E1172D与血浆HDL强相关并与APOE交互影响AD风险。
要点
- 损伤性ABCA1变异对AD风险的影响因APOE基因型而异,并与APOE ε2/ε4存在交互。
- 基于HDL相关变异预测的ABCA1活性与AD风险降低相关,且与APOE ε4交互。
- ABCA1-N1800H在细胞实验中显示质膜定位缺陷,可能由错误折叠驱动。
核心结论
- ABCA1活性的遗传修饰因子与APOE亚型交互作用,改变阿尔茨海默病风险。
研究设计与样本
- 使用阿尔茨海默病测序计划(ADSP)、UK Biobank和阿尔茨海默病欧洲测序联盟数据,在APOE亚组中评估ABCA1变异对AD风险的影响,并在全APOE队列中检验与APOE ε2和ε4的统计交互作用。
主要发现
- 损伤性非同义ABCA1变异在APOE基因型组间表现出不同的AD风险效应,并与APOE ε2和ε4存在交互效应。
- 基于HDL相关变异构建的预测ABCA1活性与AD风险降低相关,并与APOE ε4交互。
- 复制分析提示ABCA1变异在APOE组间效应量存在类似差异且效应方向一致,但在APOE交互模型中未达统计学显著性。
- ABCA1错义变异N1800H和E1172D与血浆HDL强相关,并与APOE交互影响AD风险。
- 细胞实验中ABCA1-N1800H显示质膜定位缺陷,可能由错误折叠驱动。
临床怎么用
- 在评估AD遗传风险时,可考虑ABCA1功能变异与APOE亚型的交互作用,尤其关注损伤性非同义变异及N1800H、E1172D。
- ABCA1活性预测(基于HDL相关变异)可能作为AD风险分层的补充信息,但需进一步验证。
局限性
- 复制分析中APOE交互模型未达统计学显著性。
- ABCA1活性预测基于HDL相关变异,其因果性及机制仍需实验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: ATP-binding cassette transporter A1 (ABCA1) has been associated with Alzheimer's disease (AD), but the mechanisms by which it impacts disease risk are unknown. ABCA1 is known to bind apolipoprotein E (ApoE) and catalyze apolipoprotein lipidation. We explored whether genetic variants altering ABCA1 function interact with APOE isoforms to modify AD risk. METHODS: Using data from the Alzheimer's Disease Sequencing Project (ADSP), UK Biobank, and the Alzheimer Disease European Sequencing consortium, we assessed the impact of ABCA1 variants on AD risk in APOE subgroups and tested for statistical interactions with APOE ε2 and ε4 in an all-APOE cohort. We first examined damaging nonsynonymous ABCA1 variants previously associated with AD. We then constructed a measure of predicted ABCA1 activity based on HDL-associated variants and tested its association with AD risk. Finally, we explored potential pathogenic mechanisms of missense variants of interest. RESULTS: Damaging nonsynonymous ABCA1 variants had differential AD risk effects between APOE genotype groups and exhibited interaction effects with APOE ε2 and ε4. Predicted ABCA1 activity based on HDL-associated variants was associated with reduced AD risk and interacted with APOE ε4. Replication analyses suggested similar differences in effect size of ABCA1 variants between APOE groups and had concordant effect directions, although not statistically significant, in the APOE interaction model. ABCA1 missense variants N1800H and E1172D were strongly associated with plasma HDL and interacted with APOE in AD risk. In cell-based assays, ABCA1-N1800H showed plasma membrane localization defects potentially driven by misfolding. INTERPRETATION: Genetic modifiers of ABCA1 activity interact with APOE isoforms to alter AD risk. ANN NEUROL 2026;100:737-750.
引用
- Peña-Tauber A, Hernández Arriaza R, Reil D, et al. Genetic Modifiers of ABCA1 Activity Interact with APOE Isoforms to Mediate Alzheimer's Disease Risk. Ann Neurol. 2026. PMID: 42548036. doi:10.1002/ana.78303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。